- Home
- FG vs XENE Comparison
FG vs XENE Comparison
Compare FG & XENE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | FG | XENE |
|---|---|---|
| Founded | 1959 | 1996 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Life Insurance | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.9B | 3.2B |
| IPO Year | N/A | 2014 |
Fundamental Metrics
Financial Performance| Metric | FG | XENE |
|---|---|---|
| Price | $28.36 | $41.42 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 2 | 11 |
| Target Price | $41.00 | ★ $54.09 |
| AVG Volume (30 Days) | 707.7K | ★ 896.7K |
| Earning Date | 02-19-2026 | 02-26-2026 |
| Dividend Yield | ★ 3.52% | N/A |
| EPS Growth | ★ 3428.12 | N/A |
| EPS | ★ 3.42 | N/A |
| Revenue | ★ $5,559,000,000.00 | $7,500,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $13.46 | N/A |
| P/E Ratio | $8.29 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $26.45 | $26.74 |
| 52 Week High | $47.76 | $46.60 |
Technical Indicators
Market Signals| Indicator | FG | XENE |
|---|---|---|
| Relative Strength Index (RSI) | 41.06 | 47.76 |
| Support Level | $27.44 | $40.30 |
| Resistance Level | $28.58 | $43.70 |
| Average True Range (ATR) | 0.92 | 1.53 |
| MACD | 0.05 | -0.01 |
| Stochastic Oscillator | 32.59 | 47.85 |
Price Performance
Historical ComparisonAbout FG F&G Annuities & Life Inc.
F&G Annuities & Life Inc is a provider of insurance solutions serving retail annuity and life customers as well as institutional clients. Through its insurance subsidiaries, including FGL Insurance and Fidelity & Guaranty Life Insurance Company of New York it markets a broad portfolio of deferred annuities (fixed indexed annuities (FIAs) and multi-year guarantee annuities (MYGAs) or other fixed rate annuities), immediate annuities, indexed universal life (IUL) insurance, funding agreements through funding agreement-backed notes (FABN) issuances and the Federal Home Loan Bank of Atlanta (FHLB)), and pension risk transfer (PRT) solutions.
About XENE Xenon Pharmaceuticals Inc.
Xenon Pharmaceuticals Inc is a neuroscience-focused biopharmaceutical company committed to improving the lives of people living with neurological and psychiatric disorders. It is advancing a novel product pipeline to address areas of high unmet medical need, including epilepsy and depression. The product candidates of the group include XEN1101, NBI-921352, and XEN496 for Epilepsy and Nav1.7 oral inhibitors for Pain.